TNF-alpha Inhibition in CRPS: A Randomized Controlled Trial

Summary

Studying the effects of Etanercept (an anti-Tumor Necrosis Factor alpha) on early Chronic Regional Pain Syndrome (CRPS). Our hypothesis is that Etanercept will improve patient symptoms if given in early CRPS.

Timeline

Start

2014-06

Primary completion

2016-10

Completion

2016-10

Drugs

Indications